FAKTOR-OPTIONSSCHEIN - DEXCOM Share Price

DE000SW8KEV1

Market Closed - Boerse Frankfurt Warrants 20:39:10 16/07/2024 BST
12.13 ^EUR	-5.23%

Current month	-6.52%
1 month	-1.91%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Morgan Stanley Cuts Price Target on DexCom to $120 From $132, Keeps Equalweight Rating	07-15	MT
Stifel Adjusts Price Target on DexCom to $132 From $145	07-12	MT
UPC Issues Two First Instance Decisions On Infringement	07-11	AQ
DexCom, Inc. : A Must-Have Tool for Diabetes Care	07-10

More news

Quotes 5-day view

Date	Price	Change
16/07/24	12.33	-3.67%
15/07/24	12.8	+3.06%
12/07/24	12.42	-3.27%
11/07/24	12.84	-4.18%
10/07/24	13.4	+0.15%

Real-time Boerse Frankfurt Warrants

Last update July 16, 2024 at 08:39 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Société Générale
WKN	SW8KEV
ISIN	DE000SW8KEV1
Date issued	05/04/2024
Strike	138.6 $
Maturity	Unlimited
Parity	1 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	13.79 €
Lowest since issue	8.72 €
Spread	0.06 €
Spread %	0.49%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

116.1 USD

Average target price

149.3 USD

Spread / Average Target

+28.64%

Consensus